Lisinopril vs Moxetumomab Pasudotox

## Lisinopril vs Moxetumomab Pasudotox: Overview

This comparison examines the pharmacological differences between **Lisinopril** and **Moxetumomab Pasudotox**.

## Mechanism of Action

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

## Pharmacokinetics

**Half-life**: Lisinopril — 12 hours; Moxetumomab Pasudotox — N/A.

## Chemical Properties

**Molecular Formula**: Lisinopril — C21H31N3O5; Moxetumomab Pasudotox — N/A.

**Molecular Weight**: Lisinopril — 405.4900 g/mol; Moxetumomab Pasudotox — N/A.

**Type**: Lisinopril — Small molecule; Moxetumomab Pasudotox — Antibody drug conjugate.